Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis

Affiliations

• ¹ Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, Vienna 1090, Austria.
• ² Department of Pharmacology, School of Medicine, University Complutense, Madrid, Spain.
• ³ Cardiology Division, Leiria Hospital Centre, Leiria, Portugal.
• ⁴ Department of Cardiology, Isar Heart Center, Isar Klinikum, Munich, Germany.
• ⁵ Department of Medicine, Regional Hospital West Jutland, Jutland, Denmark.
• ⁶ Department of Health, Science and Technology, Aalborg University, Aalborg, Denmark.
• ⁷ Copenhagen University Hospital (Holbaek Hospital), Holbæk, Denmark.
• ⁸ The Faculty of Medicine, Aalborg University, Aalborg, Denmark.
• ⁹ Cardiovascular Clinical Research Institute, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-IIT, Haifa, Israel.
• ¹⁰ Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.
• ¹¹ Cardiovascular and Cell Sciences Research Institute, St. George's, University of London, London, UK.
• ¹² Department of Cardiology, Oslo University Hospital Ullevål, Oslo, Norway.
• ¹³ Faculty of Medicine, University of Oslo, Oslo, Norway.
• ¹⁴ Department of Cardiovascular Science, University of Sheffield, Sheffield, UK.
• ¹⁵ University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.
• ¹⁶ Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
• ¹⁷ Radboud University Medical Centre, Nijmegen, The Netherlands.
• ¹⁸ Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, The Netherlands.